Human alpha-lactalbumin made lethal to tumors: Can it be a new intravesical therapy for bladder cancer?
Main Authors: | Amod Kumar Dwivedi, Apul Goel, S N Shankhwar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2010-01-01
|
Series: | Indian Journal of Urology |
Online Access: | http://www.indianjurol.com/article.asp?issn=0970-1591;year=2010;volume=26;issue=3;spage=464;epage=465;aulast=Dwivedi |
Similar Items
-
Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy: A novel approach of treatment
by: Rohit Kathpalia, et al.
Published: (2011-01-01) -
Is single-dose postoperative intravesical gemcitabine effective to prevent recurrence in patients with non-muscle invasive bladder cancer?
by: Abhishek Jain, et al.
Published: (2010-01-01) -
The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: A pilot study
by: Pawan Vasudeva, et al.
Published: (2008-01-01) -
Human α-lactalbumin made lethal to tumor cell death (HAMLET) mediates amyloid precursor protein (APP) in inducing cell death.
by: Toh, Kah Peng.
Published: (2010) -
Intravesical ureterocele masquerading as bladder tumor
by: Suresh Bhat, et al.
Published: (2002-01-01)